Metabolix360 offers GLP-1 weight loss medications in India as part of a comprehensive metabolic health program designed for individuals struggling with obesity or metabolic resistance. These medications, such as semaglutide (Rybelsus) and tirzepatide (Mounjaro), are clinically proven to aid in weight loss by reducing appetite, slowing digestion, and improving insulin response. At Metabolix360, GLP-1 drugs are not used as quick fixes but are integrated into a holistic plan that includes nutrition guidance, fitness routines, and lifestyle coaching. Each patient undergoes a medical assessment to determine eligibility and is monitored closely throughout the treatment. Oral and injectable options are available depending on individual needs, and the program ensures safe usage through prescription and doctor supervision. With GLP-1 medications gaining popularity in India, Metabolix360 aims to make this science-backed solution accessible and sustainable for those seeking lasting weight loss.